Blood Test Can Reveal Early Signs of Leukemia without Bone Marrow Sampling

A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics

With aging, deviation of human blood counts from their normal range accompanies the transition from health to disease. Hematopoietic stem and progenitor cells (HSPCs) deliver life-long multi-lineage output, but their variation across healthy humans with aging, and their diagnostic utility, haven’t been characterized in depth thus far. To address this, we introduced an HSPC reference model using single-cell RNA profiling of circulating CD34+ HSPC…

Leukemia risk can be detected early with blood test: study

Leukemia risk can be detected early with blood test: study

Israeli scientists unveil leukemia breakthrough just before missile demolishes resea

After surviving a direct Iranian missile hit, Israeli researchers from the Weizmann Institute revealed a groundbreaking blood test that detects early signs of leukemia and tracks blood aging—offering a painless, data-driven alternative to bone marrow biopsies and advancing cancer diagnostics worldwide

Blood test can reveal early signs of leukemia without bone marrow sampling

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in-depth studies into the biology of blood to better understand the aging process and why some people become more susceptible to disease over the years.

A potential replacement for bone marrow sampling: New blood test may detect leukemia risk

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in-depth studies into the biology of blood to better understand the aging process and why some people become more susceptible to disease over the years.